Ha habido 50 transacciones internas recientes registradas para Aerovate Therapeutics, Inc. (AVTE), incluyendo 17 compras y 33 ventas. El total de compras internas fue valorado en $15.08M y el total de ventas internas en $3.92M.
Internos destacados con actividad reciente incluyen Dake Benjamin T, Ra Capital Management, L.p., Eldridge George A. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — AVTE
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2024-08-01 |
Dake Benjamin T |
See Remarks |
Ejercicio de Opciones (Venta) |
1,507 |
$1.74 |
$2.62K |
- |
| 2024-07-31 |
Dake Benjamin T |
See Remarks |
Ejercicio de Opciones (Venta) |
10,548 |
$1.74 |
$18.35K |
1,507 |
| 2024-06-17 |
Ra Capital Management, L.p. |
10 Percent Owner |
Compra Informativa |
928,110 |
$1.67 |
$1.55M |
7,893,678 |
| 2024-06-14 |
Eldridge George A |
See Remarks |
Venta Informativa |
15,000 |
$25.03 |
$375.45K |
5,022 |
| 2024-06-14 |
Verwijs Marinus |
Chief Technical Officer |
Venta Informativa |
10,600 |
$25.00 |
$265K |
- |
| 2024-06-13 |
Gillies Hunter |
Chief Medical Officer |
Venta Informativa |
6,000 |
$24.50 |
$147K |
5,602 |
| 2024-06-05 |
Santel Donald J |
Director |
Concesión de RSU |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Ra Capital Management, L.p. |
10 Percent Owner |
Concesión de RSU |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Iwicki Mark T |
Director |
Concesión de RSU |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Dorval Allison |
Director |
Concesión de RSU |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Dable Habib J |
Director |
Concesión de RSU |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Resnick Joshua |
Director |
Concesión de RSU |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Katabi Maha |
10 Percent Owner |
Concesión de RSU |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Grayzel David S. |
Director |
Concesión de RSU |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-05-17 |
Gillies Hunter |
Chief Medical Officer |
Venta Informativa |
86 |
$21.86 |
$1.88K |
5,602 |
| 2024-05-16 |
Noyes Timothy P |
Chief Executive Officer |
Venta Informativa |
1,293 |
$21.92 |
$28.35K |
- |
| 2024-05-02 |
Verwijs Marinus |
Chief Technical Officer |
Venta Informativa |
1,981 |
$21.02 |
$41.63K |
- |
| 2024-05-01 |
Noyes Timothy P |
Chief Executive Officer |
Venta Informativa |
965 |
$20.87 |
$20.14K |
- |
| 2024-04-17 |
Gillies Hunter |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
3,497 |
$1.74 |
$6.08K |
539 |
| 2024-04-17 |
Dake Benjamin T |
See Remarks |
Venta Informativa |
68 |
$23.97 |
$1.63K |
1,291 |
| 2024-04-16 |
Noyes Timothy P |
Chief Executive Officer |
Venta Informativa |
5,509 |
$24.94 |
$137.41K |
- |
| 2024-04-10 |
Eldridge George A |
See Remarks |
Venta Informativa |
771 |
$27.56 |
$21.25K |
1,960 |
| 2024-04-09 |
Grayzel David S. |
Director |
Venta Informativa |
11,882 |
$28.15 |
$334.48K |
14,502 |
| 2024-04-01 |
Noyes Timothy P |
Chief Executive Officer |
Venta Informativa |
1,000 |
$31.95 |
$31.95K |
- |
| 2024-04-01 |
Eldridge George A |
See Remarks |
Venta Informativa |
12,495 |
$31.23 |
$390.21K |
1,960 |
| 2024-04-01 |
Dake Benjamin T |
See Remarks |
Venta Informativa |
3,325 |
$31.97 |
$106.32K |
1,291 |
| 2024-04-01 |
Verwijs Marinus |
Chief Technical Officer |
Venta Informativa |
1,504 |
$30.00 |
$45.12K |
- |
| 2024-03-28 |
Gillies Hunter |
Chief Medical Officer |
Venta Informativa |
9,000 |
$29.50 |
$265.5K |
3,251 |
| 2024-03-27 |
Dake Benjamin T |
See Remarks |
Venta Informativa |
11,068 |
$27.97 |
$309.52K |
1,291 |
| 2024-03-25 |
Dake Benjamin T |
See Remarks |
Venta Informativa |
3,432 |
$28.01 |
$96.12K |
1,291 |
| 2024-03-19 |
Verwijs Marinus |
Chief Technical Officer |
Venta Informativa |
2,764 |
$26.46 |
$73.12K |
- |
| 2024-03-18 |
Gillies Hunter |
Chief Medical Officer |
Venta Informativa |
613 |
$26.40 |
$16.18K |
3,251 |
| 2024-03-18 |
Dake Benjamin T |
See Remarks |
Venta Informativa |
7,581 |
$26.48 |
$200.76K |
1,291 |
| 2024-03-13 |
Eldridge George A |
See Remarks |
Venta Informativa |
2,016 |
$25.02 |
$50.44K |
1,960 |
| 2024-03-12 |
Eldridge George A |
See Remarks |
Venta Informativa |
2,051 |
$25.05 |
$51.37K |
1,960 |
| 2024-03-11 |
Eldridge George A |
See Remarks |
Venta Informativa |
10 |
$26.31 |
$263.05 |
1,960 |
| 2024-03-08 |
Eldridge George A |
See Remarks |
Venta Informativa |
114 |
$25.00 |
$2.85K |
1,960 |
| 2024-03-07 |
Eldridge George A |
See Remarks |
Venta Informativa |
22,386 |
$25.00 |
$559.69K |
1,960 |
| 2024-03-07 |
Gillies Hunter |
Chief Medical Officer |
Venta Informativa |
8,975 |
$24.50 |
$219.89K |
3,251 |
| 2024-03-04 |
Dable Habib J |
Director |
Concesión de RSU |
1,531 |
$22.49 |
$34.43K |
1,531 |
| 2024-02-23 |
Gillies Hunter |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
511 |
$1.74 |
$889.14 |
3,014 |
| 2024-02-20 |
Gillies Hunter |
Chief Medical Officer |
Venta Informativa |
898 |
$20.58 |
$18.48K |
3,251 |
| 2024-02-05 |
Niven Ralph |
Chief Scientific Officer |
Venta Informativa |
4,600 |
$17.45 |
$80.25K |
1,609 |
| 2024-01-29 |
Noyes Timothy P |
Chief Executive Officer |
Concesión de RSU |
200,000 |
$18.10 |
$3.62M |
200,000 |
| 2024-01-22 |
Niven Ralph |
Chief Scientific Officer |
Concesión de RSU |
66,586 |
$20.00 |
$1.33M |
66,586 |
| 2024-01-22 |
Eldridge George A |
See Remarks |
Concesión de RSU |
66,586 |
$20.00 |
$1.33M |
66,586 |
| 2024-01-22 |
Gillies Hunter |
Chief Medical Officer |
Concesión de RSU |
66,586 |
$20.00 |
$1.33M |
66,586 |
| 2024-01-22 |
Dake Benjamin T |
See Remarks |
Concesión de RSU |
66,586 |
$20.00 |
$1.33M |
66,586 |
| 2024-01-22 |
Verwijs Marinus |
Chief Technology Officer |
Concesión de RSU |
66,586 |
$20.00 |
$1.33M |
66,586 |
| 2024-01-22 |
Pigot Timothy |
Chief Commercial Officer |
Concesión de RSU |
66,586 |
$20.00 |
$1.33M |
66,586 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
